Tengfei Creation Center,55 Jiangjun Avenue, Jiangning District,Nanjing admin@sinochem-nanjing.com 3389378665@qq.com
Follow us:

Z-DL-Ala-OH

    • Product Name Z-DL-Ala-OH
    • Alias H-D-Ala(2,6-Cl2Phac)-OH
    • Einecs 259-415-2
    • Mininmum Order 1 g
    • Factory Site Tengfei Creation Center,55 Jiangjun Avenue, Jiangning District,Nanjing
    • Price Inquiry admin@sinochem-nanjing.com
    • Manufacturer Sinochem Nanjing Corporation
    • CONTACT NOW
    VTB
    Specifications

    HS Code

    442790

    Product Name Z-DL-Ala-OH
    Synonym N-Cbz-DL-alanine
    Cas Number 2104-56-5
    Molecular Formula C10H11NO4
    Molecular Weight 209.20
    Appearance White to off-white crystalline powder
    Purity Typically ≥98%
    Melting Point 104-108°C
    Solubility Slightly soluble in water, soluble in methanol and ethanol
    Storage Temperature 2-8°C
    Chemical Class Protected amino acid
    Protecting Group Carbobenzyloxy (Cbz or Z)

    As an accredited Z-DL-Ala-OH factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.

    Packing & Storage
    Packing Z-DL-Ala-OH is supplied in a clear, sealed glass vial containing 5 grams of white crystalline powder, labeled for laboratory use.
    Shipping Z-DL-Ala-OH is shipped in tightly sealed containers to protect against moisture and contamination. The chemical is transported at ambient temperature, following standard chemical safety and handling regulations. Packaging is appropriately labeled to ensure safe and compliant delivery, suitable for laboratory use upon arrival. Handle with proper protective equipment.
    Storage Z-DL-Ala-OH should be stored in a cool, dry, and well-ventilated area, away from moisture and incompatible substances. Keep the container tightly closed and protect from light. Ideally, store at 2-8°C (refrigerator). Ensure proper labeling and avoid sources of ignition or strong oxidizing agents. Follow relevant safety and regulatory guidelines for chemical storage.
    Application of Z-DL-Ala-OH

    Applications of Z-DL-Ala-OH in Industrial Manufacturing

    Z-DL-Ala-OH serves as a key protected amino acid for synthesis operations in active pharmaceutical ingredient (API) production, peptide manufacturing, specialty research reagents, biochemical assay intermediates, and advanced materials development. As a verified manufacturer, we support diverse downstream industries with consistent quality and technical documentation for process integration and regulatory compliance.

    1. Peptide Synthesis for API Production

    Pharmaceutical companies rely on Z-DL-Ala-OH as a protected alanine building block in both solid phase and solution phase peptide synthesis. Its Fmoc/Boc-compatible benzyl carbamate (Z-) protection allows precise control during multi-step assembly of therapeutic peptides, ensuring minimal racemization and controlled deprotection. Each lot undergoes full analytical release for trace metals, optical purity, and residual solvents. The quality level satisfies requirements for process development, scale-up, and commercialization of drug substance manufacturing. Our technical support covers route selection, in-process controls, and impurity profiling to fit customer regulatory filings.

    Industry compliance standards

    • ICH Q7 Good Manufacturing Practice for Active Pharmaceutical Ingredients
    • USP/EP/JP pharmacopoeial guidance (intermediate use)
    • EU Directive 2001/83/EC (GMP for medicinal products)
    • US FDA 21 CFR Parts 210-211 (where applicable)

    Typical usage ratio

    • 0.8–1.2 eq. per peptide coupling step (stoichiometry based on length and scale)
    • Exact ratio optimized for resin loading and coupling efficiency

    Downstream process integration

    • Introduced after initial resin functionalization during elongation cycles
    • Participates in carbodiimide, HATU, or DIC/HOAt coupling protocols
    • Deprotection managed via HBr, TFA, or catalytic hydrogenation as final steps

    Final product types

    • Synthetic peptide APIs (e.g., GLP-1 analogs, gonadorelin, bivalirudin)
    • Investigational peptide drugs (NCEs for clinical trials)
    • Peptide-based intermediates for combination therapies

    2. Research-Grade Custom Peptide Reagents

    Biotech laboratories and catalogue reagent producers incorporate Z-DL-Ala-OH for assembling custom peptide sequences used in antigen design, enzyme substrate development, and target validation screens. The stable Z-protection ensures compatibility with automated synthesizers and enables rapid purification. Batch traceability and impurity control guarantee assay reproducibility, critical for research reagent catalogs. We supply technical documentation including certificate of analysis (CoA), HPLC purity, and MS spectra for academic and industrial customers.

    Industry compliance standards

    • ISO 9001:2015 Quality Management Systems
    • OECD GLP (for regulated research support)
    • Supplier-specific quality control guidelines

    Typical usage ratio

    • 1–1.1 molar equivalents per residue (depending on automated synthesizer settings)
    • Adjustments based on chain length and crude purity targets

    Downstream process integration

    • Added during iterative cycle on manual or automated solid-phase peptide synthesizers
    • Optionally combined with other protected amino acids to create combinatorial libraries
    • Final deprotection strategies documented per client request

    Final product types

    • Crude and purified peptide reagents
    • Epitope mapping peptides
    • Biotinylated detection peptides
    • Labeled calibration standards for LC-MS and ELISA assays

    3. Enzyme Substrate Intermediates for Diagnostics

    Manufacturers of invitro diagnostic kits and clinical chemistry analyzers utilize Z-DL-Ala-OH as a key intermediate in the chemical synthesis of modified peptide substrates. Precise insertion of the alanine motif controls substrate specificity for proteolytic enzyme activity measurement. The compound’s purity enables endpoint and kinetic assay consistency. We provide full regulatory dossiers and batch data to support diagnostic product registration worldwide.

    Industry compliance standards

    • ISO 13485:2016 Medical Device Quality Management Systems
    • IVD Directive 98/79/EC
    • ISO 17511:2020 (traceability of values in IVD medical devices)

    Typical usage ratio

    • 0.9–1.05 molar equivalents in substrate coupling reactions
    • Optimized based on fluorescence/absorbance assay requirements

    Downstream process integration

    • Inserted at substrate elongation stage using solution phase peptide synthesis
    • Protected form enables selective modification and terminal labeling
    • Deprotection and purification followed by formulation into diagnostic vials

    Final product types

    • Chromogenic and fluorogenic enzyme substrates
    • Pre-formulated diagnostic assay kits
    • Quality control calibrators for clinical laboratories

    4. Chiral Building Block in Fine Chemical Synthesis

    Producers of specialty chemicals and advanced intermediates apply Z-DL-Ala-OH for introducing protected chiral centers in multi-step organic synthesis. The benzyl carbamate group safeguards the amine against undesired side-reactions and allows orthogonal functionalization. Analytical support includes optical purity, NMR, and residual solvent profiling. Application focuses on value-added intermediates used in crop protection actives, polymer additives, and high-performance materials.

    Industry compliance standards

    • ISO 14001:2015 Environmental Management Systems (for process safety)
    • REACH Regulation EC 1907/2006 (raw material registration in Europe)
    • Producer-specific quality assurance protocols

    Typical usage ratio

    • 1.0–2.0 equivalents per chiral coupling or derivatization step
    • Adjusted based on process yield optimization and impurity profiles

    Downstream process integration

    • Employed as a chiral input in intermediate design during organic synthesis routes
    • Enter reactions such as amidation, esterification, or polymer chain extension
    • Deprotection performed under customized conditions matching downstream functionality requirements

    Final product types

    • Enantiomerically enriched fine chemicals
    • Pesticide or fungicide intermediates
    • Polymeric monomers with functionalized side chains
    • Specialty surfactants
    Free Quote

    Competitive Z-DL-Ala-OH prices that fit your budget—flexible terms and customized quotes for every order.

    For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.

    We will respond to you as soon as possible.

    Tel: +8615371019725

    Email: admin@sinochem-nanjing.com

    Get Free Quote of Sinochem Nanjing Corporation

    Flexible payment, competitive price, premium service - Inquire now!

    Certification & Compliance
    More Introduction

    Z-DL-Ala-OH: Supporting Innovation from Our Factory Floor

    Introducing the Substance

    We manufacture Z-DL-Ala-OH at our own facilities, drawing on years of practical expertise in chemical synthesis and purification. This compound, often known as N-Carbobenzoxy-DL-alanine, plays an important role in peptide chemistry and pharmaceutical research. Through refinement of our production approach, we have managed to achieve consistent purity and reliability for research and industrial applications.

    Understanding What Sets It Apart

    From the start, handling Z-DL-Ala-OH requires more than putting raw materials together. Our synthesis process relies on tight control of temperature, pH, and reaction time, since even minor deviations lead to lower yields or unwanted byproducts. Through countless batches, we’ve identified and addressed sources of impurity, especially those that arise when producing the racemic DL form. The presence of both D- and L-alanine residues in equal proportion provides researchers with a versatile starting material where selectivity or racemic mixtures are desirable.

    Other manufacturers sometimes emphasize high yields at the expense of purity. From direct feedback and analysis, we see how persistent traces of D- or L-isomers outside the targeted blend impact downstream peptide coupling. Reliable Z-protection means less trouble when deprotecting, no extra purification steps, and fewer side reactions. Our batches routinely meet high standards for HPLC purity—our lab teams test every lot, not settling for visual checks or rough melting point measurements.

    Specifications from Practice, Not Just Paper

    Laboratory teams and production chemists often compare purchased Z-DL-Ala-OH using infrared or NMR spectra, looking for strong Cbz peaks and signs of free amino or carboxylic groups. We supply our product as a white to off-white powder, crystalline and free-flowing, balancing moisture content to avoid lumping without overdrying, which would cause static buildup during weighing. We deliver consistent melting points in each batch. The material handles predictably during dissolution—unlike some brands, our product dissolves promptly in standard polar solvents without leaving behind excessive sediment.

    Years of scaling up from gram to kilogram quantities taught us how subtle changes in recrystallization can affect color and solubility. We don’t aim for textbook perfection, but for real-world suitability: every lab and plant expects trouble-free handling. Researchers tell us their columns run more smoothly, and peptide syntheses experience fewer incomplete reactions or stubborn protecting group removals. We attribute this to our focus on real batch analysis rather than just matching data sheet numbers.

    Applications Driven by Actual Needs

    Peptide synthesizers, pharmaceutical development teams, and contract research organizations rely on reactive, clean Z-DL-Ala-OH for starter units or as intermediates in sequence assembly. Our facility supports projects ranging from analog synthesis to activity screening. The DL-form allows for flexibility—clients aren’t limited to the chirality of their starting materials, especially useful when probing biological pathways that tolerate or require racemates.

    One of the most common challenges in peptide synthesis involves keeping the α-amino group protected during coupling. The carbobenzoxy group in Z-DL-Ala-OH blocks undesired side reactions, then comes off cleanly under hydrogenolysis or mild acid. Each lot we send out is checked, not just for chemical identity, but for how well this group behaves in actual peptide formation and removal scenarios.

    Beyond peptide synthesis, customers in the agrochemical sector and academic labs report using Z-DL-Ala-OH to introduce alanine residues in chiral ligand frameworks or to study racemization mechanisms. Because we control the entire manufacturing stream, custom modifications or bulk supplies can be arranged without delays that often come with dealing through trading intermediaries.

    How We Stand Apart from Traders and Bulk Resellers

    Owning the full process eliminates guesswork when researchers or production chemists request batch records, stability data, or procedural advice. Traders and distributors often provide only forwarded certificates or scant batch history. In contrast, we readily supply detailed chromatography, mass spectra, and crystal structure data for any sample, because we generate it and review it ourselves. If a user notices unexpected NMR impurity peaks, our process chemists discuss root causes and offer technical troubleshooting.

    Having the manufacturing experience shapes our priorities. We don’t swap suppliers or switch raw starting materials for a few cents savings, since our clients notice if the material loses reactivity or introduces color bodies. Production staff routinely report back about filtration rates, cake drying times, and even packaging seals. Directly engaging with lab users gives us a clearer picture of what details matter: static charge on powders, tendency to clump under certain humidity, or how the compound holds up in long-term storage. Practical knowledge like this cannot be matched by paper specifications from non-manufacturers.

    Handling, Packaging, and Delivery Informed by Years in the Factory

    Protecting the integrity of Z-DL-Ala-OH doesn’t end at the reactor. After purification, we maintain packaging areas under low humidity to prevent caking and decomposition. Our staff check each container visibly before filling—rejecting any with irregular seams or impurities inside. Fine powders like Z-DL-Ala-OH require secure, static-resistant bottles or double-sealed bags. For bulk shipments, we take care to coordinate with logistics partners, using vibration-dampening liners to avoid compaction in transit. Feedback from clients who found unexpected lumps or moisture in competitive products pushed us to overcome these small but critical challenges.

    We also support client audits, providing open access to our operating instructions, cleaning logs, and safety measures. Transparency became our policy not because of regulatory pressure but because direct buyers demand accountability. Whenever a customer asks about quality assurance, we don’t send marketing brochures but open our records and, if requested, facilitate sample walkthroughs in our plant. That sense of direct responsibility—from synthesis to shipment—shapes every improvement we make.

    Supporting Research and Scale-Up with Real-Time Answers

    Research demands fast answers when troubleshooting or adjusting a protocol. Our manufacturing staff frequently consult with chemists working on new peptide sequences, offering direct advice on solvent choice or coupling strategies. Sometimes a researcher encounters slower-than-expected deprotection using our Z-DL-Ala-OH. Rather than referring the question out, our team reviews batch data, compares hydrogenation rates under different conditions, and gives specific, actionable recommendations. Fact-based support comes from producing and using this material in-house—not just reading about it.

    We address scaling issues for industrial clients by analyzing how temperature or material transfer in large vessels alters crystallization and purity. Some clients move from a 5-gram to a 100-kilogram process and find new bottlenecks: we’ve already faced and solved these during our own scale-ups. Whether the material is bound for a research bench or a pilot plant, our chemists understand that different settings demand different handling and can share lessons learned.

    Technical Challenges and Our Solutions

    Making a racemic amino acid with a stable carbobenzoxy group isn’t as straightforward as it might look on a formula sheet. Years ago, we struggled with local overheating during Cbz-chloride addition, leading to discoloration and incomplete reactions. By monitoring exotherms more closely and separating addition points, we lowered impurity burdens and streamlined washing. Purity checks expanded from basic TLC to full HPLC, reducing batch rework and saving time in the long run.

    Other producers ship batches without tight control of solvent residues—something that becomes obvious during downstream peptide synthesis. Solvent traces, particularly chlorinated ones, suppress coupling or introduce byproducts. We invested in vacuum drying equipment and routine GC checks, minimizing residual solvents below standard thresholds. Not until these improvements did our client rates of failed syntheses start to fall measurably.

    Addressing Waste and Environmental Responsibility

    Responsible chemical manufacturing means handling waste streams and minimizing emissions. Z-DL-Ala-OH preparations generate spent solvent and acidic or basic washings. Our facility features scrubbers and multi-stage neutralization tanks for waste minimization. Several years ago, inspection showed traces of carbobenzoxy breakdown products escaping in the water phase; staff adjusted separation times and introduced carbon filtration to correct this. Reducing hazardous waste isn’t just about compliance but about responsible stewardship for our local community—an attitude reinforced by every shift on the plant floor.

    We also work with our raw material suppliers to track and reduce upstream emissions. Modest adjustments—like optimizing delivery schedules and using bulk packaging for benzyl chloroformate—lower our carbon footprint and shrink transportation costs. Our staff spend as much time reviewing supply chain setbacks as they do refining process chemistry. While such efforts don’t directly change the quality of Z-DL-Ala-OH, they reflect our long-standing approach: sustainable production starts from the ground up.

    Partnering with End Users for Better Results

    Direct engagement with scientific users keeps us aware of emerging research directions. In recent projects, we’ve been asked about trace metals that may catalyze unwanted reactions in advanced peptide synthesis. Our internal quality team responded by lowering trace transition metal content far below industry norms, adopting new purification agents and testing methods. The effort paid off when peptide researchers reported fewer side-products in complex assemblies—something not visible without long-term feedback from those at the bench.

    Some customers also require tailored particle size or moisture content for automatic dispensing systems. By controlling the grinding and packaging environment, we meet these requirements consistently, allowing uninterrupted automation in high-throughput screening labs. Adjustments like these depend on direct manufacturer-to-user communication, ensuring technical changes take effect rapidly without delay from third-party negotiations.

    Continuous Quality Improvement Based on Operations Experience

    Feedback loops drive our entire process. Every complaint about a sticky batch, a slow-dissolving powder, or an off-color shipment prompts an internal review and, if needed, a procedural update. This is easier for us than for traders or distributors who can only pass on complaints and hope for a fix. Having our own technicians, plant operators, and analytical chemists in one location means changes get made quickly, without losing information or blaming someone else down the chain.

    We don’t see complaints as negatives but as opportunities to refine. Every adjustment—swapping a solvent, changing a filtration aid, adjusting drying time—comes from lived experience. Our improvements lead to fewer process upsets, less waste, and better product for every end user. Regular audits, not just external but from within, drive home the need to sustain high standards. Our staff know that their work affects real scientists and production teams, not just anonymous customers.

    Training, Compliance, and Long-Term Perspective

    A skilled workforce sustains our quality. We invest heavily in training new chemists—not just on paperwork but in direct, hands-on production. Practical troubleshooting, observation of crystallization, understanding the “feel” of a finished batch form part of our training. This hands-on approach stands in contrast to distant brokers who never see their products leave the bag.

    We also periodically review regulatory guidance and safety literature—even when not legally forced to do so—to keep our practices current. Our production areas meet stringent safety standards, with measures from exhaust ventilation to real-time monitoring of reaction hazards. Environmental and occupational safety don’t serve as checkboxes, but as standards that protect our workers and neighbors. Local inspectors have found our process documentation open and thorough, another benefit of full in-house control.

    The Practical Impact on Research and Development

    Supplying consistently high-quality Z-DL-Ala-OH unlocks faster research progress for our clients. Chemists report making fewer re-orders and wasting less time troubleshooting. In drug development, batch-to-batch variation in reagents leads directly to delays and unexpected costs. Our track record of stable, reproducible material means our customers can focus on new compounds, not chasing errors caused by inconsistent building blocks.

    In one case, a peptide therapeutics team documented a jump in yield and purity after switching to our Z-DL-Ala-OH. They traced the improvement to fewer extraneous signals in their HPLC readouts after coupling and deprotection—attributable to our stricter purification and handling protocols. Sharing this feedback with our plant workforce shows how their attention to detail translates directly to better science.

    Responding to Evolving Industry and Science

    As fields like peptide-based drugs, chemical biology, and green chemistry evolve, the requirements for base building blocks like Z-DL-Ala-OH keep changing. Researchers ask for documentation on source materials, batch genealogy, and environmental impact—areas where we have long-term records and direct oversight. By adapting our documentation to include traceability and process analytics, we serve not just today’s requirements but anticipate tomorrow’s expectations.

    We also participate in professional networks and consortia focused on best practices in amino acid production and peptide synthesis. Sharing lessons from our own challenges and learning from others, we continue to refine not just the chemical but every step from initial order to final delivery.

    Why Our Approach Matters

    The difference between a well-optimized, confidently delivered Z-DL-Ala-OH and one with marginal quality is apparent only to those who use it every day. From our position as direct manufacturers, every improvement, every tweak in purification or packaging, grows from what we see happen on the line and hear from our customers. Transparency and accountability come naturally, because we live with the consequences of our output. Experience tells us that quality in chemicals relies on persistent attention, honest feedback, real-world testing, and a culture that values doing things right, batch after batch.